Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (664)	$ (1,288)
Adjustment to reconcile net loss to net cash provided by (used in) operating activities
Amortization of loan discount, loan commitment and deferred financing fees	210	209
Deferred income tax benefit		3
Depreciation expense	37	55
Earnings from unconsolidated joint venture, net of distributions	18	44
Stock compensation	32	26
Changes in operating assets and liabilities:
Purchaser escrow deposits	(149)	115
Trade receivables	469	(458)
Real estate inventories	524	2,858
Other assets	550	(518)
Accrued interest	253	144
Accounts payable and accrued liabilities	(754)	(1,575)
Net cash provided by (used in) operating activities	526	(385)
Cash flows from investing activities:
Purchase of fixed assets	(1)
Principal received on note receivable	9	10
Collateral for letters of credit	(132)	(90)
Net cash used in investing activities	(124)	(80)
Cash flows from financing activities:
Proceeds from notes payable	5,499	5,209
Payments on notes payable	(5,981)	(11,175)
Loan financing costs	(71)
Distributions to non-controlling interests	(1,908)	(1,400)
Taxes paid related to net share settlement of equity awards		(4)
Net cash used in financing activities	(2,461)	(7,370)
Net decrease in cash and cash equivalents	(2,059)	(7,835)
Cash and cash equivalents, beginning of period	5,761	12,448
Cash and cash equivalents, end of period	3,702	4,613
Supplemental cash flow information:
Interest paid, net of interest capitalized	243	(65)
Supplemental disclosure for non-cash activity:
Seller's note payable	115
Accrued liability settled through issuance of stock	32	14
Increase in Series B preferred stock value in connection with dividends paid in-kind	24	$ 26
Extinguishment of Series B Preferred Stock	$ 1,011